Lancet 402:613626 Fras JP, Davies MJ, Rosenstock J et al (2021) Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes
Importantly, LBM remained largely stable, with slight gains in leg and arm FFM in some patients, resulting in minimal changes in skeletal muscle index and no cases of sarcopenia
In particular, the media have reported multi-billionaires Elon Musk, Michael Rubin, and several other high-profile celebrities using Semaglutide in an attempt to facilitate weight loss
Otherwise, we applied the Wilcoxon signed-rank test
Potential Side Effects: Reported side effects of GLP-1 receptor agonist medications commonly include nausea, vomiting, diarrhea, constipation, abdominal discomfort, headache, fatigue, and injection-site reactions